New York Angels is one of the largest and most active angel investment organizations.  Founded in 2004 as the successor organization to the NYNMA (New York New Media Association) Angel Investor Program, New York Angels is a membership organization of over 110 active angel investors and early stage venture capital funds. The group meets monthly to screen and present early stage technology companies, and its members have invested over $100 million since 2002 into over 90 ventures. In April of 2017, PItchbook identified New York Angels as #3 in their list of the 8 top VCs funding seed rounds of New York-based companies.  Among the NYA membership are nationally known angel investors including Esther Dyson and David S. Rose. The group has one full-time staff, reporting to an 11 person Board of Directors chaired by Brian S. Cohen. Dr. Elizabeth Lindsey is currently Program Director of New York Angels. Since 2012, the membership has increased by 66% and investment activity has grown by over 215%.   New York Angels concentrates on early stage investments in the range of $100,000 - $1,000,000, although it has led deals as large as $2 million. It receives over 2,200 financing applications annually, from which it selects 12-16 companies each month for an in-person screening, where all members of New York Angels are invited to attend. The group meets again for an Investment Breakfast at the end of the month, where 2-4 opportunities present to the membership with a goal to close their current investment round within two months. The group is considered a leader in the growing field of organized angel investing. It was the first member of the national Angel Capital Association, hosted the ACA Summit conference in 2006, and was the initial test group for the now-standard gust (Angelsoft) funding platform.  Membership as an investor in New York Angels is by invitation only, and members are required to commit to investing at least $50,000 annually in early stage technology deals, in addition to the group's $3,500 annual membership dues.  Requests for funding for entrepreneurial ventures may be self-submitted through the group's website. New York Angels charges no fees to entrepreneurs.

New York Angels

Sand Hill Angels is a group of Silicon Valley angel investors passionate about helping entrepreneurs get to the next level. What makes the group unique is the collective experience of its members building and scaling deep technology companies. The group has been around for more than two decades. Sand Hill Angels works openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.  For additional information, visit www.sandhillangels.com or follow @SandHillAngels.com on Twitter.

Sand Hill Angels

Rockies Venture Club (RVC) is a non-profit organization dedicated to economic development by funding entrepreneurial companies. RVC hosts the Angel Capital Summit and Colorado Capital Conferences as well as over sixty events each year. Rockies Venture Club is also an active Angel group, with over 30 investments in the last 2 years. Alongside Rockies Venture Club, is Rockies Venture Fund I, an Angel sidecar fund.

Rockies Venture Club

Founded in 1972, the Broe Group practices investing with patience to optimally realize value for entrepreneurs and stakeholders it partners with.    The Broe Group invests with technology and healthcare technology firms to complement its portfolio of asset heavy holdings in the transportation, real estate and energy industries.  As a long term partner, the Broe Group provides entrepreneurs with resources beyond capital with access to a diverse network of individuals and organizations.

Three Leaf Ventures

Founded by Jean Balgrosky, HIT lecturer at UCLA with 20 years of CIO experience in the healthcare industry, and Parker Hinshaw, founder of maxIT, Bootstrap Incubation's mission is to invest in and mentor start-up healthcare technology businesses to achieve the American Dream. Bootstrap Incubation is a world class and complimentary team of experienced entrepreneurs with execution in their DNA.

Bootstrap Incubation

The Colorado Impact Fund is a private equity fund dedicated to supporting local companies that generate consistent investment returns in addition to positive community outcomes.  Their investors include some of Colorado’s most respected executives, families, foundations and corporations, each of whom is committed to making a difference in the State of Colorado and beyond. Managed by an affiliate of Vestar Capital Partners, the Colorado Impact Fund provides growth capital to entrepreneurs who have developed compelling business models that drive meaningful financial returns and community impact.  Their team is committed to helping portfolio companies reach their potential. Their  investment strategy leverages their collective experiences, resources, and networks to help Colorado entrepreneurs create exceptional and lasting companies. Energy and passion are core to who they are and they seek to partner with entrepreneurs and company builders equally dedicated to accelerating their businesses.

The Colorado Impact Fund

Service Provider Capital is a venture capital fund that co-invests in series A deals led by institutional venture funds. It was founded in 2014 and is based in Golden, Colorado.

Service Provider Capital

Drive Capital invests in innovative technology, healthcare, and consumer companies in the Midwest. The firm is looking for innovative entrepreneurs addressing big market opportunities. Its goal is to partner with entrepreneurs that have audacious goals and strive to build large sustainable companies. The firm seeks to invest in information technology, financial services, and mobile sectors. It was founded in 2012 and is headquartered in Columbus, Ohio.

Drive Capital

The 7wire Ventures’ vision is to use the power of mobility, connected devices, the cloud, and sophisticated analytics to further advance industries like healthcare and education. We like to make a difference in things that matter.  The firm was founded on the concept of disrupting the status quo—supporting new ideas, technologies, approaches, and business models for solving society’s most important problems.  7wire Ventures provides funding and operating guidance to companies that challenge the “way things are done.” Through the creation of new businesses, investments in early and growth stage companies, and by complementing funds with insight and experience, we have a track record of transforming great ideas into world-class companies.

7wire Ventures

CirrusMD

CirrusMD is a text-first enterprise solution that connects people and doctors with no-barriers access to human experts who can always help. It develops a solution to deliver guidance beyond primary care.  The company was founded in 2012 and is headquartered in Denver, Colorado.

<div>CirrusMD is a business-to-business (B2B) telehealth provider that connects employees and doctors for 24/7 care. The company claims that it has facilitated more than 500 million texts and 350,000 encounters between its members and practitioners. CirrusMD&rsquo;s platform, which is available in all 50 states, gives patients access to board-certified physicians via its mobile app or online. It supports voice chat, video chat, and photo sharing in addition to text messaging.</div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

<div>
 
 CirrusMD is a business-to-business (B2B) telehealth provider that connects employees and doctors for 24/7 care. The company claims that it has facilitated more than 500 million texts and 350,000 encounters between its members and practitioners. CirrusMD&rsquo;s platform, which is available in all 50 states, gives patients access to board-certified physicians via its mobile app or online. It supports voice chat, video chat, and photo sharing in addition to text messaging.
 
 
 
 
 Key customers and partnerships
 
 
 In September 2023, CirrusMD expanded its work with the United States Department of Veteran Affairs (VA) to offer VA Health Chat to over 5.1 million Veterans in additional states, including West Virginia, Maryland, Wisconsin, and Illinois. VA Health Chat was a platform developed to provide Veterans with immediate access to care through a chat format. It allowed Veterans to control the conversation and access care when needed. The platform is staffed by VA healthcare professionals and offers a safe and secure communication channel with schedulers, nurses, pharmacists, physicians, and non-clinical/administrative staff.&nbsp;
 
 
 
 
 Funding and financials
 
 
 CirrusMD completed a Series C funding round in March 2021 that brought the company&rsquo;s total funds raised to USD 46 million.
 
</div>

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

<div>
 
 Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications. 
 
 
 Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.
 
</div>

Amicomed

<div>
 
 Winston is a men&rsquo;s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients. 
 
 
 The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.
 
</div>

Winston

<div>
 
 Eko Health is a cardiopulmonary digital health company that aims to improve heart and lung care for patients using sensors and artificial intelligence. The company produces connected handheld digital stethoscopes with electrocardiogram functionality to detect heart rhythm abnormalities using artificial intelligence (AI) algorithms. In 2020, the company obtained 501(k) FDA clearance for multiple algorithms that help detect heart murmurs and atrial fibrillation, or AFib. These algorithms were used in 2022 to develop the Eko App, which pairs to the company's stethoscopes for report generation, information sharing and carrying out examinations. 
 
 
 The company operates on a fee per unit B2B2C model and a D2C model, where it provides its technology to medical practitioners or patients for diagnostic purposes.
 
 
 In February 2023, Eko 
 <a href="https://sp-edge.com/updates/16677">
 launched SENSORA
 </a>
 , a cardiac disease detection platform that combines the company&rsquo;s existing digital stethoscopes with a machine learning-based platform. The platform enables primary care physicians to detect structural murmurs and assess heart arrhythmias by using a database of heart sounds to compare and identify anomalies in a patient's heart beat. 
 
 
 In April 2024, Eko 
 <a href="https://sp-edge.com/updates/28111">
 obtained FDA 510(k) clearance
 </a>
 for its AI-aided cardiac tool, Eko Low Ejection Fraction Tool (ELEFT). The tool is designed to assist providers in early detection of low ejection fraction, a significant sign of heart failure.
 
 
 Funding and financials
 
 
 In March 2022, raised a further USD 30 million in an extension to its Series C round, which began November 2020. The total funds raised by the company stood at USD 126 million as of March. These funds have been allocated to support further commercialization efforts and develop new products for the company.
 
 
 
 
 
 
 
</div>

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

CirrusMD

Telehealth

Key stats

Recent Updates

CirrusMD expands partnership with US Department of Veterans Affairs

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless